William Blair, Sofi and Affirm

William Blair raised their Q4 2024 EPS estimates for LPL Financial in a report released on Monday, January 13th. William ...
"It is my pleasure to welcome Terence to William Blair’s Healthcare investment banking practice and its biopharma group," said Steve Tole, head of Healthcare investment banking at William Blair. "Our ...
William Blair Small-Mid Cap Growth Fund earns a Below Average Process Pillar rating. The process benefits from its parent firm's long-term risk-adjusted performance, as shown by the firm's average ...
Equities research analysts at William Blair lowered their FY2025 earnings estimates for shares of MarketAxess in a research ...
William Blair initiated coverage of Elevation Oncology (ELEV) with an Outperform rating without a price target The shares offer “high potential reward for a relatively low upfront investment ...
William Blair Small Cap Growth Fund earns an Average Process Pillar rating. The leading factor in the rating is the fund's strong long-term risk-adjusted performance. This can be seen in its ten ...
Equities research analysts at William Blair dropped their Q4 2025 EPS estimates for Zumiez in a research report issued on ...